Get started
Author

Pierluigi Blanc

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 144
PDF
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network
2017 · Loreta A. Kondili, Giovanni Battista Gaeta, et al. · PLoS ONE · 115
PDF
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents
2007 · Andrea Gabbuti, Luisa Romanò, et al. · Vaccine · 109
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial
2021 · Francesco Menichetti, Patrizia Popoli, et al. · JAMA Network Open · 66
PDF
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study
2018 · Roberta Gagliardini, Arturo Ciccullo, et al. · Open Forum Infectious Diseases · 65
PDF
Increased Creatine Kinase May Predict A Worse COVID-19 Outcome
2021 · Daniele Orsucci, Michele Trezzi, et al. · Journal of Clinical Medicine · 48
PDF
Posters (Abstracts 301–2389)
2018 · Loreta A. Kondili, Maria Giovanna Quaranta, et al. · Hepatology · 44
PDF
Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
2018 · Loreta A. Kondili, Sarah Robbins, et al. · Liver International · 44
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors
2015 · Andrea De Luca, Simona Di Giambenedetto, et al. · Open Forum Infectious Diseases · 39
PDF
A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort
2021 · Loreta A. Kondili, Monica Monti, et al. · Hepatology · 37
Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study
2020 · Carlo Pallotto, Lorenzo Roberto Suardi, et al. · Scandinavian Journal of Infectious Diseases · 35
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
2018 · Massimiliano Fabbiani, Roberta Gagliardini, et al. · Journal of Antimicrobial Chemotherapy · 32
PDF
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
2017 · Loreta A. Kondili, Federica Romano, et al. · Hepatology · 32
PDF
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
2021 · Carlo Pallotto, Pierluigi Blanc, et al. · Journal of Infection · 27
PDF
Potential remdesivir‐related transient bradycardia in patients with coronavirus disease 2019 (COVID‐19)
2021 · Carlo Pallotto, Lorenzo R. Suardi, et al. · Journal of Medical Virology · 24
PDF
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach
2020 · Lorenzo Roberto Suardi, Carlo Pallotto, et al. · International Journal of Infectious Diseases · 22
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
2023 · Giuseppina Brancaccio, Barbara Coco, et al. · International Journal of Infectious Diseases · 19
PDF
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)
2023 · Tommaso Manciulli, Michele Spinicci, et al. · Viruses · 19
PDF
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study
2024 · Anna Barbiero, Michele Spinicci, et al. · Microorganisms · 17
PDF
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
2023 · Loreta A. Kondili, Maria Giovanna Quaranta, et al. · Digestive and Liver Disease · 17
PDF
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
2024 · Antonella d’Arminio Monforte, Alessandro Tavelli, et al. · Journal of Antimicrobial Chemotherapy · 15
PDF
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort
2020 · on behalf of PITER Collaborating Group, Maria Giovanna Quaranta, et al. · Hepatology International · 15
PDF
Chlamydia Pneumoniae Seropositivity and Cardiovascular Risk Factors: The InCHIANTI Study
2004 · Pierluigi Blanc, Anna Maria Corsi, et al. · Journal of the American Geriatrics Society · 15
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
2024 · Loreta A. Kondili, Giuseppina Brancaccio, et al. · International Journal of Infectious Diseases · 14
PDF
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART
2018 · Francesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, et al. · Journal of Antimicrobial Chemotherapy · 12
PDF
Works count: 62
Citation count: 1,118
H-index: 18
I10-index: 27
Year
Topic
Type